Indiana: Saxenda litigation | DrugsMonitor.com

Saxenda litigation in Indiana (IN): Consumer snapshot of claims themes, timing cues, and requesting help—not legal advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., Indiana